2Shinno H, Inagaki T, Miyaoda, et al. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gynus are as-sociated with behavioral and psychological symptoms in Alzheimer's disease [ J ]. Journal of the Neurological Sciences,2007,260 ( 1 - 2 ) : 132 - 138.
3Konaka K, Ueda H, Li JY, et at, N-acetylaspartate to Total Creatine Ratio in the Hippocampal CA/ Sector after Transient Cerebral Ischemia in Gerbils:Influence of Neuronal Elements, Reactive Gliosis, mad Tissue Atrophy [ J ]. J Cereb Blood Flow Metab ,2003,23 (6) :700 - 708.
4Vermathen P, Capizzano AA, Maudsley AA. Ad ministration and 1 H- MRS Detection of Histidine in Human Brain : Application to in Vivo pH Measurement[ J ]. Magn Reson Med ,2000,43 ( 5 ) :665 - 675.
5Jessen F, Block W, Traber F, et al. Pronto MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial tepmporal lobe of patients with AD [ J ]. Neurology,2000,55 (5) :684.
6Predo J Modego. Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment [ J ]. Current Alzheimers Research ,2006,3 ( 2 ) : 161 - 170.
7Schuff N, Capizzano AA, Du AT, et al. Selective reduction of Naeetylaspartate in medial temporal and parietal lobes in AD [ J ]. Neurology,2002,58 (7) :928 - 935.
8Kantarci K, Petersen RC, Boeve BF, et al. 1H-MRS spectroscopy study in connnon dementias [ J]. Neurology, 2004,63 ( 2 ) : 161 - 170.
9Jessen F, Gtir O, Block W, et al. A multicenter ( 1 ) H-MRS study of the medial temporal lobe in AD and MCI [ J ]. Neurology, 2009,72 (20) :1735 - 1740.
6Atlas SW. Magnetic resonance imaging of the brain and spine. 3rd edition. New York:Philadelphia Lippincott Williams and Wilkins, 2002 : 1189.
7Waldman AD, Rai GS, McConnell JR, et al. Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and sub-cortical ischemic vascular dementia in older people. Arch Gerontol Geriatr, 2002, 35: 137-142.
8Vogt BA, Finch DM, Olson CK. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cerebral Cortex, 1992, 2: 435-443.
9Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology, 2001, 56: 592-598.
10Krishnan KR, Charles HC, Doraiswamy PM, et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry, 2003, 160 : 2003-2011.
1Petersen R C. Mild cognitive impairment: current research and clinical implications[J]. Semin Neurol,2007,27(1):22-31.
2Zimny A, Bladowska J, Neska M, et al. Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment[J]. Med Sci Monit,2013,19:86-94.
3Wolf H, Grunwald M, Kruggel F, et al. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly[J]. Neurobiol Aging,2001,22(2): 177-186.
4Kantarci K, Jack C J, Xu Y C, et al. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water[J]. Radiology,2001,219(1): 101-107.
